Inicio / Hematología / Abstracts de hematología / The impact of cytogenetic…

The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)

0 / 5 (0 votos)
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)

American Journal of Hematology

Fecha de publicación: 17 September 2020

DOI: https://doi.org/10.1002/ajh.26000

Autores: Salamat Ali, Tofeeq Ur-Rehman, Mashhood Ali, Sayeed Haque, Faisal Rasheed, Eleri Lougher, Muhammad Sarfraz Nawaz & Vibhu Paudyal 

Background: Karyotypic analysis at time of diagnosis has an important value in determining initial response to treatment, remission duration and overall survival (OS) in acute myeloid leukemia (AML). Less is known about its value before allogeneic hematopoietic cell transplantation (allo‐HCT) in patients transplanted with active disease, either relapsed or primary refractory (Rel‐Ref) AML.

Leer más

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.